Quarterly report pursuant to Section 13 or 15(d)

Acquisitions, Investments, and Licenses - Schedule of Consolidated Assets and Non-Recourse Liabilities (Details)

v2.4.0.8
Acquisitions, Investments, and Licenses - Schedule of Consolidated Assets and Non-Recourse Liabilities (Details) (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2014
Dec. 31, 2013
Jun. 30, 2013
Dec. 31, 2012
Current assets:        
Cash and cash equivalents $ 134,010 [1] $ 185,798 [1] $ 119,061 $ 27,361
Accounts receivable, net 23,113 [1] 19,767 [1]    
Inventory, net 18,334 [1] 18,079 [1]    
Prepaid expenses and other current assets 7,553 [1] 19,084 [1]    
Total current assets 183,010 [1] 242,728 [1]    
Property, plant and equipment, net 17,348 [1] 17,027 [1]    
Intangible assets, net 69,059 [1] 74,533 [1]    
Goodwill 226,001 [1] 226,373 [1]    
Other assets 4,910 [1] 6,861 [1]    
Total assets 1,327,082 [1] 1,391,516 [1]    
Current liabilities:        
Accounts payable 10,041 [1] 13,414 [1]    
Accrued expenses 54,964 [1] 65,874 [1]    
Total current liabilities 79,402 [1] 91,850 [1]    
Other long-term liabilities 218,490 [1] 214,775 [1]    
Total liabilities 414,257 [1] 518,537 [1]    
SciVac | Variable Interest Entity, Primary Beneficiary
       
Current assets:        
Cash and cash equivalents 433 2    
Accounts receivable, net 516 283    
Inventory, net 1,700 1,696    
Prepaid expenses and other current assets 529 218    
Total current assets 3,178 2,199    
Property, plant and equipment, net 1,412 1,374    
Intangible assets, net 1,055 1,111    
Goodwill 1,757 1,821    
Other assets 263 261    
Total assets 7,665 6,766    
Current liabilities:        
Accounts payable 1,007 1,136    
Accrued expenses 8,298 6,498    
Notes payable 3,903 1,537    
Total current liabilities 13,208 9,171    
Other long-term liabilities 261 1,240    
Total liabilities $ 13,469 $ 10,411    
[1] As of June 30, 2014 and December 31, 2013, total assets include $7.7 million and $6.7 million, respectively, and total liabilities include $13.5 million and $10.4 million, respectively, related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.